Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Retinoblastoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Temozolomide 32Radiotherapy 11Magnetic Resonance Spectroscopy 11Carboplatin 10Bevacizumab 10Irinotecan 9Carmustine 9Filgrastim 8Erlotinib Hydrochloride 8Surgical Procedures, Operative 7sargramostim 5Imatinib Mesylate 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5temsirolimus 4Vorinostat 4Sirolimus 4Procarbazine 4Peripheral Blood Stem Cell Transplantation 4O(6)-benzylguanine 4aldesleukin 3Thalidomide 3Iodine-125 3Immunohistochemistry 3Gadolinium DTPA 3Cyclophosphamide 3Bortezomib 3Biopsy 3lonafarnib 2imetelstat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × becatecarin × Sarcoma × Clear all
NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
200 enrolled
CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡